| Product Code: ETC7592299 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iran Non-Small Cell Lung Cancer Diagnostics Market Overview |
3.1 Iran Country Macro Economic Indicators |
3.2 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Iran Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle |
3.4 Iran Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces |
3.5 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F |
3.8 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Iran Non-Small Cell Lung Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer in Iran |
4.2.2 Growing awareness about the importance of early detection and diagnosis |
4.2.3 Advancements in diagnostic technologies and techniques |
4.3 Market Restraints |
4.3.1 High costs associated with diagnostic tests and procedures |
4.3.2 Limited access to advanced diagnostic facilities in certain regions of Iran |
4.3.3 Regulatory challenges and compliance issues affecting the market |
5 Iran Non-Small Cell Lung Cancer Diagnostics Market Trends |
6 Iran Non-Small Cell Lung Cancer Diagnostics Market, By Types |
6.1 Iran Non-Small Cell Lung Cancer Diagnostics Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021- 2031F |
6.1.4 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021- 2031F |
6.1.5 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Large Cell Carcinoma, 2021- 2031F |
6.1.6 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Iran Non-Small Cell Lung Cancer Diagnostics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F |
6.2.3 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Instruments And Services & Softwares, 2021- 2031F |
6.3 Iran Non-Small Cell Lung Cancer Diagnostics Market, By Test |
6.3.1 Overview and Analysis |
6.3.2 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.3.3 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Molecular Test, 2021- 2031F |
6.3.4 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.5 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Sputum Cytology, 2021- 2031F |
6.3.6 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Thoracentesis, 2021- 2031F |
6.3.7 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.4 Iran Non-Small Cell Lung Cancer Diagnostics Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.4.4 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Academics, 2021- 2031F |
6.4.5 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Iran Non-Small Cell Lung Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Iran Non-Small Cell Lung Cancer Diagnostics Market Export to Major Countries |
7.2 Iran Non-Small Cell Lung Cancer Diagnostics Market Imports from Major Countries |
8 Iran Non-Small Cell Lung Cancer Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of new diagnostic technologies in non-small cell lung cancer diagnosis |
8.2 Percentage of diagnosed cases at early stages |
8.3 Rate of growth in collaborations between healthcare providers and diagnostic companies |
9 Iran Non-Small Cell Lung Cancer Diagnostics Market - Opportunity Assessment |
9.1 Iran Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Iran Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Iran Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F |
9.4 Iran Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Iran Non-Small Cell Lung Cancer Diagnostics Market - Competitive Landscape |
10.1 Iran Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Iran Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here